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Abstract
In eukaryotic cell types, virtually all cellular processes are under control of proline-directed kinases and especially MAP
kinases. Serine/threonine kinases in general were originally considered as a eukaryote-specific enzyme family. However,
recent studies have revealed that orthologues of eukaryotic serine/threonine kinases exist in bacteria. Moreover, various
pathogenic species, such as Yersinia and Mycobacterium, require serine/threonine kinases for successful invasion of human
host cells. The substrates targeted by bacterial serine/threonine kinases have remained largely unknown. Here we report
that the serine/threonine kinase PknB from the important pathogen Staphylococcus aureus is released into the external
milieu, which opens up the possibility that PknB does not only phosphorylate bacterial proteins but also proteins of the
human host. To identify possible human targets of purified PknB, we studied in vitro phosphorylation of peptide microarrays
and detected 68 possible human targets for phosphorylation. These results show that PknB is a proline-directed kinase with
MAP kinase-like enzymatic activity. As the potential cellular targets for PknB are involved in apoptosis, immune responses,
transport, and metabolism, PknB secretion may help the bacterium to evade intracellular killing and facilitate its growth. In
apparent agreement with this notion, phosphorylation of the host-cell response coordinating transcription factor ATF-2 by
PknB was confirmed by mass spectrometry. Taken together, our results identify PknB as the first prokaryotic representative
of the proline-directed kinase/MAP kinase family of enzymes.
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Introduction
Despite their clinical relevance, the mechanisms employed by
pathogenic bacteria to subvert the host immune system remain
only partially characterised. It has become clear, however, that
pathogens create a beneficial environment for their survival by
secreting proteins that mimic the functions of several host proteins.
One of the best known bacterial examples is Yersinia pestis, the
plague bacterium, which injects its effector proteins into the host
cells by the type III secretion system [1,2]. These Yersinia effector
(Yop) proteins include the eukaryotic-like serine/threonine kinase
YpkA, also known as YopO [3]. This kinase shows a high degree
of sequence similarity to mammalian serine/threonine protein
kinase domains. YpkA is translocated into a host cell where it
disrupts the actin-based cytoskeletal system and promotes both
survival and replication of bacteria by an unknown mechanism
[3,4,5]. Nevertheless, the full spectrum of human proteins that are
phosphorylated by YpkA has remained elusive so far [6].
Eukaryotic-like serine/threonine protein kinases (STPKs) are
present not only in the Yersinia genus, but they have also been
identified in the soil microorganism Myxococcus xanthus [7,8] and in
human pathogens, such as Mycobacterium tuberculosis, which even
encodes 11 STPKs. Only two of these (PknG and PknK) are
soluble proteins, while the other nine STPKs contain a
transmembrane domain [9]. Moreover STPKs have also been
identified in Pseudomonas aeruginosa [10,11], Streptococcus pneumoniae
[12,13,14] and in Staphylococcus aureus [15,16,17]. However, the
precise biological functions and substrate specificities of these
kinases have not yet been defined.
Recently, attention has been focussed on the PknB kinase of S.
aureus. This Gram-positive bacterium is part of the human
microbiota, but it can turn into a dangerous pathogen, causing a
wide range of infections [18,19,20]. Although S. aureus is mostly
considered as an extracellular pathogen, it can invade a variety of
mammalian non-professional cells, such as nasal endothelial cells.
Moreover S. aureus survives phagocytosis by professional phago-
cytes [21,22,23], such as neutrophils [24,25], mouse or rat
macrophages [26,27,28,29], and human macrophages [30,31].
To overcome the stressful conditions imposed by its host, S. aureus
has evolved various protective and offensive responses
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activation and inactivation of response regulators [36,37]. This is
generally achieved through cascades of phosphorylation reactions
in the host, which focuses a strong interest on the role of kinases,
such as the serine/threonine kinase PknB (also known as StpK) in
staphylococcal persistence.
The PknB kinase is composed of three extracellular PASTA
domains (penicillin binding domains), a central transmembrane
domain and an intracellular kinase domain [16,38]. Interestingly,
it was recently reported that PknB is not only involved in
regulation of the central metabolism of S. aureus [15], but also
determines staphylococcal infection of mouse kidneys in an abscess
model [17]. The latter observation raises the question whether the
kinase activity of PknB is directly or indirectly involved in the
pathogenicity of S. aureus. A direct role of PknB in infection is
conceivable since serine/threonine kinases play key roles in
mammalian cell signalling, and at least two bacterial equivalents,
YpkA of Yersinia and PknG of Mycobacterium tuberculosis, have been
shown to be directly involved in the subversion of host cells during
the respective infectious processes [39,40]. However the exact role
played by PknB in pathogenesis or staphylococcal persistence has
thus far remained unclear.
Here we show that full-size soluble PknB is present in the
medium of growing S. aureus cells. We therefore investigated
whether PknB of S. aureus can recognize and phosphorylate known
substrates of human serine/threonine kinases. For this purpose, we
used peptide microarrays with known human phosphorylation
sites. The phosphorylation profile and mass spectrometry results
show that PknB is a proline-directed kinase, which can indeed
phosphorylate specific human targets. The observed target
specificity of PknB indicates possible roles for this enzyme in a
wide range of host cell signalling processes during S. aureus
infection.
Results and Discussion
Identification of Extracellular PknB
It has previously been reported that different bacteria such as
M. tuberculosis and Yersinia species can secrete their eukaryotic-like
serine/threonine kinases directly into the host. This mechanism
allows these bacteria to survive intracellularly [9,39], to disrupt the
actin cytoskeleton [41], or to cause host cell apoptosis [40]. Since
these bacterial ser/thr kinases need to be exported in order to
impact on host cells, we investigated whether PknB might be
detectable in the extracellular milieu of S. aureus. As shown by
Western blotting using polyclonal antibodies against PknB, the
full-size PknB was detectable both in the cellular and growth
medium fractions of cells of S. aureus NCTC 8325 harvested at an
OD600 of 2. As expected, PknB was neither detectable in cellular
nor growth medium fractions of the DpknB mutant. The precise
mechanism by which PknB is liberated from the wild-type cells
remains to be elucidated. However, there is precedence for the
release of membrane proteins, or fragments thereof, into the
extracellular milieu of Gram-positive bacteria, such as S. aureus,b y
as yet unknown mechanisms [42]. One possibility is that these
proteins are released by cell lysis, remaining stable in the medium
due to an intrinsic resistance to extracytoplasmic proteolysis [43].
The idea that PknB is released by lysis would be consistent with the
detection of relatively small amounts of the cytoplasmic marker
protein thioredoxin A (TrxA) in the growth medium fractions
(Fig. 1). TrxA is a cytoplasmic bacterial protein, which acts as an
antioxidant by facilitating the reduction of cysteine disulfides in
other cytoplasmic proteins. Since TrxA is normally a cytoplasmic
protein, it will only be found in the extracellular milieu when
bacterial cells have lysed. Notably, compared to the cellular
samples, we detected relatively more extracellular PknB than
extracellular TrxA, which might suggest that the release of PknB is
the consequence of a specific process rather than cell lysis.
Irrespective of the mechanism by which PknB is released into
the extracellular milieu of S. aureus, its release may impact on
human host cell functions. This could be the case upon
internalization of S. aureus. Although S. aureus is primarily an
extracellular pathogen, there is strong evidence that it can be
internalized by a wide range of human host cells. For example, S.
aureus invades non-professional phagocytes by a mechanism which
requires a specific interaction between the bacterial fibronectin-
binding protein and the host cell [44,45,46]. This leads to host
signal transduction, activation of tyrosine kinases, cytoskeletal
rearrangement and endosome uptake. Bayles and Qazi reported
that internalized S. aureus is able to escape from the host endosome,
and this fact opens up the possibility of direct interactions of
released PknB with proteins of the human host [47,48]
Eukaryotic Phosphorylation Sites Recognized by PknB
Peptide arrays (PepChips) have previously been used success-
fully to profile the activity of kinases in eukaryotic cell lysates [49].
We therefore employed this array-based technology to investigate
whether the staphylococcal kinase PknB has the ability to
recognize and phosphorylate human phosphorylation sites. When
the PepChips were incubated with purified and active PknB [16]
and [
33P-c] ATP, radioactivity was efficiently incorporated in a
particular subset of the peptides on the chip. In contrast, little
radioactivity was incorporated when the arrays were incubated
with [
33P-c] ATP in the absence of PknB. We identified 68
Figure 1. Release of PknB into the growth medium of S. aureus.
The S. aureus strain NCTC 8325 (wt) or a DpknB derivative were
propagated at 37uC in TSB and harvested at OD600 2. Crude extracts (ce)
and supernatant (sup) fractions were isolated, corrected for OD and
separated by NuPAGE electrophoresis (Invitrogen). Two-fold higher
amounts of the supernatant fractions were used for PAGE as compared
to the crude extracts. Immunoblotting was conducted using specific
antibodies against PknB (upper panel) or TrxA (lower panel). The latter
served as an indicator for cell lysis. The position of the specific PknB
signal is marked with a black arrow. The band at ,60 kDA corresponds
to an unidentified protein, which cross-reacts with the antibodies
against PknB. The molecular weight of marker proteins is indicated on
the left.
doi:10.1371/journal.pone.0009057.g001
PknB Phosphorylation Profile
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9057potential substrates for PknB, of which the biological functions are
summarised in Table 1 (for details, see Table S1). Interestingly, 32
of the potential human substrates of PknB are involved in signal
transduction and cell communication. The identified peptides
include serine/threonine kinases, cell cycle control proteins, and
regulators of protein phosphorylation such as adaptor molecules.
Our results suggest that any active PknB released from invasive S.
aureus cells may target signal transduction mechanisms for host cell
subversion. In addition, 13 potential PknB substrates are involved
in gene regulation, including transcription factors, transcription
regulatory proteins and RNA binding proteins. Three potential
substrates play a role in immune responses and recognition, five in
transport processes, ten in cell growth and maintenance
(cytoskeletal and structural proteins), two in cell metabolism, two
in stress responses, and one in apoptosis.
Phosphorylation of the identified potential human PknB targets
would result in significant changes in host cell signal transduction.
One of the peptides that is best phosphorylated by PknB
(
64IVADQTPTPTR
74) is derived from the Activating Transcrip-
tion Factor-2 (ATF-2) (see Table S2). ATF-2 belongs to the bZIP
(Basic Leucine Zipper Domain) DNA-binding protein family and
is expressed by almost all human cells (GeneNote, Ensemlb ID:
ENSG00000115966). In unstimulated cells, ATF-2 is maintained
in an inactive form by interactions between its own activation
domain and its bZIP domain [50]. In response to certain stimuli
[51,52,53], the kinases p38 and JNK phosphorylate ATF-2 at
amino acids Thr69 and Thr71 [52,53]. The phosphorylated ATF-
2 can then form homodimers and heterodimers [54], which bind
with high affinity to the consensus sequence 59-TGACGTCA-39
[55] in target gene promoters, resulting in their activation. The
phosphorylation of ATF-2 thus results in the expression of a broad
spectrum of proteins implicated in different processes, such as cell
cycle molecules (cyclin D1) [56], cell adhesion molecules [57],
growth factors [58], anti-apoptotic factors [59], and invasion-
related molecules [60].
To confirm that PknB is able to phosphorylate ATF-2, we
incubated ATF-2 with PknB in vitro and performed mass
spectrometric analyses. As a positive control we incubated ATF-
2 with p38. The results show that PknB can indeed phosphorylate
ATF-2 (Fig. 2). However, PknB phosphorylated Thr73, whereas
p38 phosphorylated Thr69 and Thr71. Interestingly, Thr73 is the
known phosphorylation site of the Human Vaccinia-related
Kinase 1 (VRK1) [61]. VRK1 is a ser/thr kinase overexpressed
in proliferating cells [62,63]. Phosphorylation of ATF-2 on Thr 73
by VRK1 kinase leads to the activation of ATF-2 and,
consequently, the induction of cellular protection mechanisms.
Another peptide that was very efficiently phosphorylated by
PknB belongs to the Bcl-2 interacting protein Bim (see Table S2).
In vivo this peptide is recognized by the c-Jun NH2-terminal kinase
(JNK) (Table S1) [64,65]. Bim is a member of the pro-apoptotic
Bcl-2 family of proteins, which play a critical role in apoptosis
regulation. A short peptide motif, DKSTQT
56P, which is present
in BimL and BimEL, but absent from BimS, mediates the binding
of Bim to the LC8 cytoplasmic dynein light chain. Importantly, the
same motif is also recognized and phosphorylated by PknB (Table
S1). Exposure of cells to stress causes the activation of JNK kinase,
which phosphorylates Bim at Thr56 in the afore-mentioned
DKSTQTP motif. The phosphorylation leads to conformational
changes in Bim and subsequent dissociation of Bim from dynein
motor complexes [66]. The activated Bim may directly activate
pro-apoptotic Bax, or indirectly activate Bax by binding anti-
apoptotic Bcl-2 family proteins (e.g., Bcl-2 and Bcl-XL) [67,68].
Judged by the observed phosporylation of the DKSTQT
56P
peptide, the release of PknB from invasive S. aureus cells might have
similar effects as its phosphorylation by JNK.
A third intriguing target of PknB identified through phosphorylation
profiling is the cytoskeleton-associated protein paxillin. This protein has
previously been reported as a target for the phosphatase YopH, which
is injected by Yersinia into human host cells, thereby affecting
cytoskeleton integrity [69]. Taken together, the identified potential
targets of PknB are fully consistent with previously reported effects of S.
aureus and other bacteria on host cell apoptosis [70,71,72,73] and a
wide range of cellular processes [4,6,13,39,40,74,75].
Interestingly, a comparison of the identified human phosphor-
ylation sites of PknB with staphylococcal proteins revealed about
300 putative PknB target sequences in proteins of S. aureus (data
not shown). These include amino acid sequences in proteins that
are known to be phosphorylated by PknB, such as triosephosphate
isomerase, DnaK, elongation factors, ribosomal proteins and
trigger factor [15].
PknB Is a Proline-Directed Serine/Threonine Kinase
To determine which amino acids are preferably phosphorylated
by PknB, we generated a sequence logo based on the 15% best-
Table 1. Cellular processes that can be targeted by PknB.
Transport
Total: 5 proteins
Cell growth and maintanance
Total: 10 proteins
membrane transport proteins, voltage gated channel, water channel proteins structural proteins, cell cycle regulation proteins, cell adhesion proteins
Metabolism
Total: 2 proteins
Immune response and recognition
Total: 3 proteins
phosphotransferase, ribosomal subunit immunoglobulin, cell surface receptors
Signal transduction and Cell communication
Total: 32 proteins
Regulation of nucleobase, nucleoside, nucleotide and nucleic acid
metabolism
Total: 13 proteins
receptors, cell cycle proteins, cell junction proteins, serine/threonine kinases,
tyrosine kinases, transport/cargo proteins, adapter molecules
DNA binding site, RNA binding site, ribonucleoproteins, transcription factors,
transcription regulatory proteins
Apoptosis
Total: 1 protein
Stress
Total: 2 proteins
Bcl2- interacting protein BIM Heat-shock proteins
Functional classes of human proteins that are potentially phosphorylated by PknB, as identified in the present PepChip analysis, are classified by their biological
function.
doi:10.1371/journal.pone.0009057.t001
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PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9057Figure 2. Verification of PknB-dependent phosphorylation of ATF-2. Recombinant ATF-2 was incubated with PknB (A) or p38 (B) in kinase
reaction buffer for 30 minutes at 37uC. As a control, ATF-2 was incubated with PknB in the absence of ATP. After tryptic digestion, the resulting
peptides were analyzed via online-mass spectrometry. The panels show the spectra for the ATF-2 peptide VIVADQTPTPTR that was either
phosphorylated at the Thr73 by PknB, or Thr 69 and Thr 71 by p38. The b- and y-ions are high-lighted and the observed masses are given. Also the
peptide sequence is indicated and amino acids that have been identified my mass spectrometric analysis are indicated in bold letters. The upper
sequence corresponds to the b- and the lower sequence to the y-ions.
doi:10.1371/journal.pone.0009057.g002
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amino acids in PknB-phosphorylated peptides are serine and
threonine. This observation is in agreement with the serine/
threonine kinase signature in the primary sequence of PknB.
Apparently, the signature has portability across the eukaryotic/
prokaryotic divides. Nevertheless tyrosine phosphorylation can
also be unambiguously identified making this study the first
demonstration of enzymatic tyrosine kinase activity in a single
isolated prokaryotic enzyme. What is also clearly evident in the
sequence logo is the presence of a proline residue next to
phosphorylated serine, threonine or tyrosine residues. Thus, it
seems that proline is part of the PknB recognition and target
sequence. This links PknB to the evolutionary well-conserved
family of proline-directed kinases, which includes cyclin-depen-
dent protein kinases (CDKs), mitogen-activated protein kinases
(MAP kinases) and glycogen synthase kinase-3 (GSK-3; Fig. 3).
These kinases play a crucial role in cell cycle, transcription, signal
transduction and are involved in many diseases like cancer or
Alzheimer’s disease [76,77,78]. Like the eukaryotic MAP kinases,
PknB has the ability to phosphorylate ATF-2 at least in vitro, which
implies that PknB has a MAP kinase-like enzymatic activity. This
view is supported by the observation that PknB is also involved in
the regulation of important cellular functions in S. aureus, including
central metabolic pathways [15] and cell wall metabolism [79].
Taken together, our results imply that PknB is the first prokaryotic
representative of the proline-directed kinases, a cardinal family of
regulators of eukaryotic cellular physiology. A major challenge for
future studies will be to identify human proteins that are
phosphorylated by PknB in vivo, for example upon internalization
of S. aureus by macrophages.
Materials and Methods
Detection of Extracellular PknB by Immunoblotting
S. aureus NCTC 8325 or a pknB mutant of this strain [16] were
cultivated in 10 ml of TSB (37uC, 250 rpm) and growth was
monitored by OD600 readings. Samples of 3 ml were harvested at
OD600 2 and cells were separated from the growth medium by
centrifugation (8000 rpm, 5 min, 4uC). Bacterial cells were washed
in PBS, resuspended in sample buffer (NuPage, Invitrogen) and
disrupted using a Precellys 24 bead beater (three times 30 s,
6800 rpm; Bertin Technologies). Proteins from the growth
medium fraction were collected by TCA-acetone precipitation
[80]. Protein samples were mixed with gel-loading buffer with
reducing agent and incubated for 5 min at 95uC. To receive a
clear signal for the supernatant fractions twice as much as from the
crude extract was applied to gel electrophoresis. The proteins were
separated on a 10% Bis-Tris gel (Invitrogen) at 200 V for 35 min
in NuPAGEH MES SDS Running Buffer (Invitrogen). The
separated proteins were transferred to a nitrocellulose membrane
(ProtranH, Schleicher and Schuell) by semi-dry blotting at 200 mA
for 75 min. Membranes were blocked for one hour in Blocking
Buffer (Odyssey, Li-Cor biosciences). Rabbit primary antibodies
against the kinase domain of PknB were added (1:5000 in blocking
buffer) and membranes were incubated for 1 hour. Next,
membranes were washed 3 times for 5 minutes in PBS-T
(Phosphate Buffered Saline Tween-20) before adding a fluorescent
secondary antibody at a 1:20000 dilution in blocking buffer
(IRDye 800 CW goat anti-rabbit antibody from LiCor bioscienc-
es). Membranes were incubated for 1 hour in the dark, washed
three times for 5 min in PBS-T and once in PBS. After
Figure 3. Sequence logo of PknB phosphorylation sites and comparison to known phosphorylation sites of human kinases. The
image shows consensus recognition sites for the staphylococcal PknB and other proline-directed ser/thr kinases.
doi:10.1371/journal.pone.0009057.g003
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using the Odyssey Infrared Imaging System (LiCor Biosciences).
As a cell lysis control, antibodies against cytoplasmic protein TrxA
were used in the same concentration as PknB antibodies.
Cloning, Expression and Purification of S. aureus TrxA
All procedures for DNA purification, restriction, ligation,
agarose gel electrophoresis, and transformation of competent E.
coli DH5a cells were carried out as previously described [81].
Genomic DNA of S. aureus RN4220 [82] was isolated using the
Genelute Bacterial Genomic DNA kit (Sigma). The trxA gene on
this genomic DNA was PCR-amplified using the primers
GGGGGCATATGGCAATCGTAAAAGTAA and GGGGGC-
TCGAGTAAATGTTTATCTAAAACTTC. The PCR product
was cloned into HincII (HindII) restricted pUC18 [83]. After
verification of the sequence, the trxA gene was excised from this
plasmid with NdeI and XhoI, and ligated into the same restriction
sites of pET26b(+) (Novagen, Inc.), downstream of the T7
promoter and upstream of an in-frame His(6)tag sequence. The
resulting pET26-SatrxA plasmid was checked by sequencing and
used to transform E. coli BL21(DE3) (Invitrogen) for high-level trxA
expression and purification. 10 ml of an overnight culture of this
strain was used to inoculate 1 liter fresh LB medium and grown
until an OD600 of 0.7 was reached. Then, isopropylthiogalactoside
(IPTG) was added to a final concentration of 1 mM to induce
TrxA production. After 3 hrs of induction, cells were harvested by
centrifugation and resuspended in binding buffer (20 mM NaPi,
300 mM NaCl, 10% (v/v) glycerol, 5 mM imidazole, 3 mM
DTT, pH 7.4). Next, cells were disrupted by two passages through
a French Press (2500 PSI). Cellular debris was removed by
centrifugation (30 min at 30000 g, 4uC), and the clarified
supernatant fraction was applied to a nickel-charged IMAC
column (5 ml HisTrap HP, GE Healthcare). Unbound sample was
washed from the column with binding buffer using an A ¨KTA
explorer (GE Healthcare). Next, the His-tagged TrxA protein was
eluted from the column using binding buffer with a gradient of
increasing imidazole concentrations (up to 500 mM imidazole).
The eluted fractions were checked for the presence of pure TrxA
protein using SDS-PAGE and subsequent silver-staining. Further
purification was achieved by concentrating the proteins with
Vivaspin columns (Vivascience) and loading them on a Superdex
75 gel filtration column (Amersham) pre-equilibrated with 20 mM
NaPi, 150 mM NaCl, 10% glycerol and 3.5 mM DTT, pH 7.4.
Fractions containing the purified TrxA proteins were pooled and
dialyzed 3 times against 20 mM Tris-HCl, pH 7.6, with 150 mM
NaCl. Specific polyclonal antibodies against the purified TrxA
protein were raised in rabbits (Eurogentec).
Kinome Array Analysis
PepChip
TM Kinomics slides containing 976 fully annotated,
disease-related kinase phosphorylation sites in triplicate (Pepscan,
Lelystad, The Netherlands, http://www.pepscan.com/) were incu-
bated with 50 ml of the ser/thr kinase PknB incubation mix (0.8 mg/
ml PknB kinase domain, 60 mM HEPES, pH 7.5, 3 mM MgCl2,
3m MM n C l 2, 1 mM DTT, 50% glycerol, 50 mM ATP supple-
mented with 1Mbq [c-
33P] ATP, 0.03% Brij-35, 50 mg/ml bovine
serum albumin, 3 mM Na3VO4,5 0mg/ml PEG 8000) for 90 min in
a humidified incubator. As a negative control we used the ‘‘empty’’
incubation mix without PknB. After incubation the peptide arrays
were washed twice in 2 M NaCl (1% Tween-20) and PBS-T. Next,
the arrays were rinsed twice in demineralised water and air-dried.
The dried slides were transferred to a phosphor imager plate (Fuji
Storm 860, Stanford, GE, USA) and exposed for 72 hours. The
density of the spots was measured and analyzed with array software.
Peptide Array Data Analysis
To analyze the intensity of spots and to correct for background
phosphorylation, the ScanAnalyze software and grid tools were
used, and the resulting data were exported to an excel sheet. Three
replicate data sets were taken for further statistical analysis. To this
end, the Spearman correlation coefficient was calculated for each
combination of the three sets. The average and standard deviation
for each peptide were determined and plotted in an amplitude-
based hierarchical fashion. If only background phosphorylation is
present, this amplitude-based distribution can be described by a
single exponent. Thus, determining the exponent describing
amplitude behavior of the 500 least phosphorylated peptides
should give an adequate description of array background
phosphorylation and, in practice, this was indeed the case. 125
Peptides which exhibited the incorporation of c-
33P in the absence
of added kinase were excluded from further analysis. Peptides of
which the average phosphorylation minus 1.96 times the standard
deviation was higher as the value expected from describing the
background distribution were considered to represent true
phosphorylation events. Two-sided heteroscedastic t-tests were
also performed on each set of values to determine significance
(p,0.05).
Sequence Logos
Sequence logos were created with the weblogo server at http://
weblogo.berkeley.edu/logo.cgi using either the preferred sub-
strates of PknB, or known phosphorylation sequences for human
kinases as available at http://www.phosphosite.org/homeAction.
do
In Vitro Phosphorylation of ATF-2 by Staphylococcal
PknB
In order to confirm the phosphorylation of ATF-2 by PknB, the
in vitro assay was performed. Purified staphylococcal kinase PknB
(26 mg) was incubated with 50 mg of Activating Transcription
Factor fusion protein (Cell Signaling) in kinase incubation mix
(50 mM HEPES, 1 mM DTT, 0.01 Brij35, 3 mM MnCl2,3m M
MgCl2,5 0mM ATP) for 30 minutes at 37uC in waterbath. As a
positive control, 0.1 mg of p38-alpha MAP kinase (Cell Signaling)
was incubated with 50 mg of ATF-2. As negative controls, the
following reaction mixtures were used: PknB with ATF-2 but
without ATP; PknB with ATP but without ATF-2; and ATF-2
with ATP but without PknB.
Phosphorylation Site Identification and Protein
Identification by Mass Spectrometry
Trypsin (Promega) was activated by 15 min incubation at 30uC
in activation buffer and then added 1:200 to the samples, digestion
was allowed to proceed over night at 37uC. The resulting peptides
were separated by liquid chromatography and measured online by
ESI-mass spectrometry using a nanoACQUITY UPLC
TM system
(Waters, Milford, MA) coupled to an LTQ Orbitrap
TM mass
spectrometer (Thermo Fisher Scientific, Waltham, MA). Peptides
were desalted onto a trap column (SymmetryH C18, Waters).
Elution was performed onto an analytical column (BEH130 C18,
Waters) by a binary gradient of buffer A (0.1% (v/v) acetic acid)
and B (100% (v/v) acetonitrile, 0.1% (v/v) acetic acid) over a
period of 50 min with a flow rate of 400 nl/min. The LTQ
Orbitrap was operated in data-dependent MS/MS mode using
MSA for phospho-relevant masses. Proteins were identified by
searching all MS/MS spectra in .dta format against all S. aureus
NCTC 8325 proteins and added ATF-2 protein (extracted from
the NCBI database) using Sorcerer
TM-SEQUESTH (ThermoFin-
PknB Phosphorylation Profile
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with a fragment ion mass tolerance of 1.00 Da and a parent ion
tolerance of 10 ppm. Up to two missed tryptic cleavages were
allowed. Methionine oxidation (+15.99492 Da), Carbamido-
methylation (+57.021465 Da) and phosphorylation of STY
(+79.966331 Da) was set as variable modification. Proteins were
identified by at least two peptides applying a stringent SEQUEST
filter. Sequest identifications required at least deltaCn scores of
greater than 0.10 and XCorr scores of greater than 1.9, 2.2, 3.75
and 3.75 for singly, doubly, triply and quadruply charged peptides.
Phosphorylated peptides which passed this filter were examined
manually and accepted only, when b- or y- ions confirmed the
phosphorylation site.
Supporting Information
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